Sign In
Buy HRMY
$35.24
-0.620 (-1.73%)
At Close: Jul 31, 2026
Harmony Biosciences Holdings, Inc. (HRMY) Q2 2025 Earnings Call Transcript
04:04pm, Tuesday, 05'th Aug 2025
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY ) Q2 2025 Earnings Conference Call August 5, 2025 8:30 AM ET Company Participants Adam Zaeske - Executive VP & Chief Commercial Officer Brennan Doyle -
Harmony Biosciences Holdings, Inc. (HRMY) Misses Q2 Earnings and Revenue Estimates
09:40am, Tuesday, 05'th Aug 2025
Harmony Biosciences Holdings, Inc. (HRMY) came out with quarterly earnings of $0.68 per share, missing the Zacks Consensus Estimate of $0.78 per share. This compares to earnings of $0.2 per share a ye
PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) today announced plans to announce topline data from its phase 3 registrational clinical trial of ZYN002 in Fra
Harmony Biosciences Holdings, Inc. (HRMY) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
11:01am, Tuesday, 29'th Jul 2025
Harmony Biosciences (HRMY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
5 High Earnings Yield Stocks to Tap Into Value Investing Gains
09:56am, Tuesday, 22'nd Jul 2025
Unlock value with IAG, PAGP, HOPE, COMM and HRMY, five stocks with high earnings yields and strong growth signals.
Harmony Biosciences to Report Second Quarter 2025 Financial Results on August 5, 2025
08:05am, Tuesday, 22'nd Jul 2025
PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) today announced that it will report second quarter 2025 financial results on Tuesday, August 5, 2025, before t
Why Harmony Biosciences (HRMY) is Poised to Beat Earnings Estimates Again
01:11pm, Thursday, 17'th Jul 2025
Harmony Biosciences (HRMY) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
3 Reasons Growth Investors Will Love Harmony Biosciences (HRMY)
01:46pm, Tuesday, 15'th Jul 2025
Harmony Biosciences (HRMY) could produce exceptional returns because of its solid growth attributes.
HRMY vs. ILMN: Which Stock Should Value Investors Buy Now?
12:41pm, Tuesday, 15'th Jul 2025
Investors interested in stocks from the Medical - Biomedical and Genetics sector have probably already heard of Harmony Biosciences Holdings, Inc. (HRMY) and Illumina (ILMN). But which of these two co
Does Harmony Biosciences (HRMY) Have the Potential to Rally 43.19% as Wall Street Analysts Expect?
10:56am, Tuesday, 15'th Jul 2025
The average of price targets set by Wall Street analysts indicates a potential upside of 43.2% in Harmony Biosciences (HRMY). While the effectiveness of this highly sought-after metric is questionable
Is Harmony Biosciences (HRMY) Stock Undervalued Right Now?
10:41am, Tuesday, 15'th Jul 2025
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
Harmony Biosciences to Participate in H.C. Wainwright "HCW@Home" Series
08:05am, Tuesday, 15'th Jul 2025
PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY), today announced that Harmony's management team will participate in the virtual H.C. Wainwright "HCW@Home" ser
Here's Why Harmony Biosciences Is an Unconventional Cannabis Investment
08:50am, Friday, 04'th Jul 2025
HRMY isn't your typical cannabis play - its synthetic CBD gel targets rare brain disorders with no approved therapies.
PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) today announced the presentation of preclinical pharmacological effect data for BP1.15205, an investigational,
Harmony Biosciences Strengthens Patent Position With Favorable Settlement in ANDA Litigation
08:05am, Thursday, 05'th Jun 2025
PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY), today announced a settlement agreement with Lupin Limited, resolving the patent infringement litigation relat
